MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$17,119,438
Interest income
$437,931
Other income, net
$421,125
Loss from operations
-$17,978,494
Total operating
expenses
$17,978,494
Research and development
$11,514,123
General and
administrative
$6,464,371
Back
Back
Income Statement
source: myfinsight.com
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)